New Therapies on the Horizon
LaMP clinicians and researchers are actively working to promote better insight into clinical questions, and to leverage opportunities to develop joint translational projects to be launched in the next year. In addition to the diagnosis and initial treatment of leukemia and myeloma, we believe it is just as important to know when to treat, how much to treat, and which subset of patients will benefit from each type of therapy. Given that most major breakthroughs in these diseases have come from basic research, LaMP will promote fast-tracking these discoveries into the clinic by building strong interactions between scientific researchers and front-line physicians.
Please stay tuned for developments.